摘要
由SARS-CoV-2引起的新冠肺炎疫情最初于2019年12月在武汉爆发。截至2020年3月22日,该疾病蔓延到186个国家,至少有305275例确诊病例。虽然疫情在中国的蔓延有所下降,但尽管各国政府和国际社会采取了遏制措施,全球COVID-19流行情况依然严重。本文系统回顾了COVID-19疫情的简史、流行情况和临床特点,重点阐述了我国防治新冠肺炎的策略,为其他国家应对新冠肺炎疫情提供参考。这次流行病强调必须不断警惕全球动态和个别国家环境的变化, 确保所有人都知道哪些方法在预防、控制和治疗新疾病方面是成功的, 并且要有足够的灵活性来适应相应的情况。
关键词: 新冠肺炎,SARS-CoV-2,2019-nCov,冠状病毒,肺炎疫情。
图形摘要
Current Cancer Drug Targets
Title:COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide
Volume: 20 Issue: 6
关键词: 新冠肺炎,SARS-CoV-2,2019-nCov,冠状病毒,肺炎疫情。
摘要: The outbreak of COVID-19 due to SARS-CoV-2 originally emerged in Wuhan in December 2019. As of March 22, 2020, the disease spread to 186 countries, with at least 305,275 confirmed cases. Although there has been a decline in the spread of the disease in China, the prevalence of COVID-19 around the world remains serious despite containment efforts undertaken by national authorities and the international community. In this article, we systematically review the brief history of COVID-19 and its epidemic and clinical characteristics, highlighting the strategies used to control and prevent the disease in China, which may help other countries respond to the outbreak. This pandemic emphasizes the need to be constantly alert to shifts in both the global dynamics and the contexts of individual countries, making sure that all are aware of which approaches are successful for the prevention, containment and treatment of new diseases, and being flexible enough to adapt the responses accordingly.
Export Options
About this article
Cite this article as:
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide, Current Cancer Drug Targets 2020; 20 (6) . https://dx.doi.org/10.2174/1568009620666200414151419
DOI https://dx.doi.org/10.2174/1568009620666200414151419 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antiviral Activity of Phytochemicals: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review
Current Pharmaceutical Biotechnology Withdrawal Notice: Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell
Current Pharmaceutical Design Global Clinical Trials for the Treatment of TB with Thioridazine
Recent Patents on Anti-Infective Drug Discovery Docking Simulations Exhibit Bortezomib and other Boron-containing Peptidomimetics as Potential Inhibitors of SARS-CoV-2 Main Protease
Current Chemical Biology In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening
Medicinal Chemistry Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker
Infectious Disorders - Drug Targets Treatment Approaches for COVID-19: A Critical Review
Mini-Reviews in Medicinal Chemistry Virtual Screening, Molecular Docking and <i>In silico</i> ADME-Tox Analysis for Identification of Potential Main Protease (Mpro) Enzyme Inhibitors
Anti-Infective Agents Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology In Vitro Data of Current Therapies for SARS-CoV-2
Current Medicinal Chemistry The Identification, Characterization and Optimization of Small Molecule Probes of Cysteine Proteases: Experiences of the Penn Center for Molecular Discovery with Cathepsin B and Cathepsin L
Current Topics in Medicinal Chemistry Investigation of Structural, Treatment, and Clinical Characteristics of COVID-19 Along with the Challenges Caused by its Prevalence
Infectious Disorders - Drug Targets The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
Recent Patents on Anti-Cancer Drug Discovery Chemoinfectomics in Drug Design and Development
Anti-Infective Agents The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19
Current Stem Cell Research & Therapy COVID-19 Infection and Vitamin D: Current Scenario and Future Prospects
Current Drug Discovery Technologies Diagnostic Stewardship in Times of COVID-19 Pandemic
Infectious Disorders - Drug Targets COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review
Current Pediatric Reviews